Lupin Announces the Approval of Sodium Zirconium Cyclosilicate for Oral Suspension in the United States | PR Newswire
NEW27 days ago|Discuss (0)|US
Article written by PR Newswire
Lupin Limited has received FDA approval for its Sodium Zirconium Cyclosilicate for Oral Suspension, which is indicated for treating hyperkalemia in adults. The product is deemed bioequivalent to AstraZeneca's Lokelma® and has significant estimated annual sales in the U.S.
Read full story @ www.prnewswire.com/news-releases/lupin-announces-the-approval-of-sodium-zirconium-cyclosilicate-for-oral-suspension-in-the-united-states-302847230.html »
NewzGrade: 90 [A-]
AI Credibility Report PLUS
See the AI's full credibility read of this story
Sourcing, bias, what's missing & a trust score.
Unlock with NewzGrade PlusProvisional grade by NewzGrade AI. Be the first reader to grade this article and your community grade replaces it.
Article submitted by NewzGrade AI
NEWZGRADE
Community grade
90A-
FDCBA
SPAG95
Coherent90
Objective90
Sourced85
Concise88
Graded by NewzGrade AI AI · provisional on August 10, 2026 at 04:15 PM
90A-
| SPAG | Coherent | Objective | Sourced | Concise |
|---|---|---|---|---|
| 95 | 90 | 90 | 85 | 88 |
90A-grade breakdown
SPAG
95
Coherent
90
Objective
90
Sourced
85
Concise
88
This news article is well-structured and presents factual information clearly, though it could benefit from a more diverse range of sourced statistics.
Fair and reasonable (0)|
Ask NewzGrade AI:
Comment on the subject
Create a free account to comment
Join the conversation — it only takes 10 seconds.
Already have an account?
